Modeling late-onset Alzheimer's disease neuropathology via direct neuronal reprogramming

Area of Science:

• Neuroscience
• Genetics
• Cell Biology

Background:

• Late-onset Alzheimer's disease (LOAD) is the most prevalent form of Alzheimer's disease (AD).
• Developing accurate models for sporadic LOAD, capturing pathologies like amyloid-β (Aβ) deposition and neurodegeneration, is crucial but challenging.
• Existing models often fail to fully replicate the complex neuropathology observed in patients.

Purpose of the Study:

• To establish a novel in vitro model for sporadic LOAD using direct neuronal reprogramming.
• To investigate the recapitulation of key AD neuropathological features in reprogrammed neurons.
• To explore potential therapeutic targets by manipulating specific cellular pathways.

Main Methods:

• Utilized microRNA (miRNA)-based direct reprogramming to convert fibroblasts from AD patients into neurons.
• Cultured reprogrammed neurons in a three-dimensional environment to mimic brain tissue.
• Administered β- or γ-secretase inhibitors and investigated the role of retrotransposable elements in neurodegeneration.

Main Results:

• Reprogrammed neurons from LOAD patients effectively recapitulated AD neuropathologies, including Aβ deposition and neurodegeneration.
• Early intervention with secretase inhibitors prevented Aβ-dependent neuronal death.
• Inhibition of age-associated retrotransposable elements reduced both Aβ deposition and neurodegeneration in LOAD neurons.

Conclusions:

• miRNA-based direct reprogramming provides a powerful and efficient method for modeling late-onset Alzheimer's disease neuropathology.
• This model system allows for the study of Aβ-dependent neurodegeneration and the evaluation of therapeutic interventions.
• Targeting retrotransposable elements presents a potential novel strategy for mitigating LOAD progression.